Assessing the feasibility of a platform trial for Gram negative bloodstream infections: results from the vanguard phase of BALANCE.

Saved in:
Bibliographic Details
Title: Assessing the feasibility of a platform trial for Gram negative bloodstream infections: results from the vanguard phase of BALANCE.
Authors: Daneman N; Division of Infectious Diseases, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada Nick.Daneman@sunnybrook.ca., Johnstone J; Division of Infectious Diseases, Sinai Health/University Health Network, Department of Medicine, University of Toronto, Toronto, Ontario, Canada., Lee TC; Division of Infectious Diseases, Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada., MacFadden DR; Department of Medicine, University of Ottawa, The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada., McDonald EG; Division of General Internal Medicine, Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada., Morpeth SC; Department of Microbiology and Infectious Diseases, Middlemore Hospital, University of Auckland, Auckland, New Zealand., Ong SWX; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada., Paterson DL; ADVANCE-ID, Saw Swee Hock School of Public Health, National University of Singapore, Singapore., Pinto RL; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada., Rishu A; Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada., Rogers BA; Centre for Inflammatory Diseases, Monash University School of Clinical Sciences at Monash Health, Clayton, Victoria, Australia., Yahav D; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; Infectious Diseases Unit, Sheba Medical Center, Ramat-Gan, Israel., Coburn B; Division of Infectious Diseases, University Health Network, University of Toronto, Toronto, Ontario, Canada., Daley P; Division of Infectious Diseases, Memorial University, Newfoundland, Newfoundland, Canada., Das P; Division of Infectious Diseases, North York General Hospital, Toronto, Ontario, Canada., Fiest K; Critical Care Medicine, University of Calgary, Calgary, Alberta, Canada., Findlater A; Division of Infectious Diseases, Niagara Health, St. Catharines, Ontario, Canada., Fralick M; Division of General Internal Medicine, Sinai Health, Toronto, Ontario, Canada., George M; Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada., Kandel C; Division of Infectious Diseases, Michael Garron Hospital, Toronto, Ontario, Canada., Malavade A; Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada., Powis J; Division of Infectious Diseases, Michael Garron Hospital, Toronto, Ontario, Canada., Somayaji R; Division of Infectious Diseases, Department of Medicine, University of Calgary, Calgary, Alberta, Canada., Fowler R; Department of Medicine and Department of Critical Care Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.
Corporate Authors: BALANCE+ Investigators, and the Association of Medical Microbiology and Infectious Disease Canada Clinical Research Network and the Canadian Critical Care Trials Group
Source: BMJ open [BMJ Open] 2025 Dec 05; Vol. 15 (12), pp. e101588. Date of Electronic Publication: 2025 Dec 05.
Publication Type: Evaluation Study; Journal Article
Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-6055 (Electronic) Linking ISSN: 20446055 NLM ISO Abbreviation: BMJ Open Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2044-6055
DOI:10.1136/bmjopen-2025-101588